CJ Wheeler,
KL Black,
G Liu,
H Ying,
JS Yu,
W Zhang,
PK Lee.
(2003)
" Thymic CD8+ T cell production strongly influences tumor antigen recognition and age-dependent glioma mortality.
"
J Immunol
171.
4927-33
PMID:
14568975
|
Abstract and Keywords
P Zajac,
D Oertli,
W Marti,
M Adamina,
M Bolli,
U Guller,
C Noppen,
E Padovan,
E Schultz-Thater,
M Heberer,
G Spagnoli.
(2003)
" Phase I/II clinical trial of a nonreplicative vaccinia virus expressing multiple HLA-A0201-restricted tumor-associated epitopes and costimulatory molecules in metastatic melanoma patients.
"
Hum Gene Ther
14.
1497-510
PMID:
14577912
DOI:
10.1089/104303403322495016
|
Abstract and Keywords
LH Butterfield,
A Ribas,
VB Dissette,
Y Lee,
JQ Yang,
P De la Rocha,
SD Duran,
J Hernandez,
E Seja,
DM Potter,
WH McBride,
R Finn,
JA Glaspy,
JS Economou.
(2006)
" A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides.
"
Clin Cancer Res
12.
2817-25
PMID:
16675576
DOI:
10.1158/1078-0432.CCR-05-2856
|
Abstract and Keywords
H Okada,
P Kalinski,
R Ueda,
A Hoji,
G Kohanbash,
TE Donegan,
AH Mintz,
JA Engh,
DL Bartlett,
CK Brown,
H Zeh,
MP Holtzman,
TA Reinhart,
TL Whiteside,
LH Butterfield,
RL Hamilton,
DM Potter,
IF Pollack,
AM Salazar,
FS Lieberman.
(2010)
" Induction of CD8+ T-Cell Responses Against Novel Glioma-Associated Antigen Peptides and Clinical Activity by Vaccinations With {alpha}-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma.
"
J Clin Oncol
29.
330-6
PMID:
21149657
DOI:
10.1200/JCO.2010.30.7744
|
Abstract and Keywords
OE Rahma,
E Ashtar,
M Czystowska,
ME Szajnik,
E Wieckowski,
S Bernstein,
VE Herrin,
MA Shams,
SM Steinberg,
M Merino,
W Gooding,
C Visus,
AB Deleo,
JK Wolf,
JG Bell,
JA Berzofsky,
TL Whiteside,
SN Khleif.
(2011)
" A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients.
"
Cancer Immunol Immunother
61.
373-84
PMID:
21927947
DOI:
10.1007/s00262-011-1100-9
|
Abstract and Keywords